Picture of Bicycle Therapeutics logo

BCYC Bicycle Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Brief: Bicycle Therapeutics Says Cash Position Of $293.8 Million At March 31, Excludes $50 Million Upfront Payment From Novartis, Expected To Provide Financial Runway Into 2025

May 4 (Reuters) - Bicycle Therapeutics PLC  BCYC.O :
    * BICYCLE THERAPEUTICS - CASH POSITION OF $293.8 MILLION AT
MARCH
31, EXCLUDES $50 MILLION UPFRONT PAYMENT FROM NOVARTIS, EXPECTED
TO PROVIDE FINANCIAL RUNWAY INTO 2025
    * QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $1.30
    * Q1 EARNINGS PER SHARE VIEW $-1.07 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw2q0t4Ba 
Further company coverage:  BCYC.O 

 ((Reuters.Brief@thomsonreuters.com;))

Recent news on Bicycle Therapeutics

See all news